Article thumbnail

Hypertension among adults in a deprived urban area of Peru - undiagnosed and uncontrolled?

By Alisha R Davies, J Jaime Miranda, Robert H Gilman and Liam Smeeth

Abstract

BACKGROUND: In Peru, cardiovascular disease was the second most common cause of death in those aged 65 years or more in 2000. Hypertension is a major modifiable risk factor for cardiovascular disease, and if treated can significantly reduce cardiovascular disease risk. The objectives of this study were to investigate the prevalence of hypertension and levels of awareness, treatment and control in a deprived urban area of Peru. METHODS: A cross-sectional study was completed. Blood pressure measurements were recorded in triplicate. Hypertension was defined as systolic blood pressure >/= 140 mmHg or diastolic blood pressure >/= 90 mmHg, or self report of receiving antihypertensive medication at the time of interview. RESULTS: The study sample was 584 adults (29.1% male, mean age 35.3 years). Age standardized prevalence of hypertension was 19.5% (95% CI 9.9%, 29.1%) in men, 11.4% (95% CI 3.7%, 19.1%) in women, and 13.2% (95% CI 5.0%, 21.5%) overall. Among those with hypertension 38.3% (95% CI 22.7%, 53.9%, n = 18/47) were aware of their condition with greater awareness among women than men. Of those aware, 61.1% (n = 11/18) were treated, equating to 23.4% (95% CI 10.1%, 36.7%, n = 11/47) of all adults with hypertension. Of those treated 63.6% (n = 7/11) had controlled hypertension, equating to 14.9% (95% CI 3.0%, 26.8%, n = 7/47) of all adults with hypertension. CONCLUSION: Levels of awareness and control in this population were low. Lack of control is likely to be due to both a failure to diagnose hypertension, especially among men, and initiate or comply with treatment, especially among women. These results suggest a considerable burden of undiagnosed hypertension, and poor levels of control in those treated, in a deprived urban area of Lima, Peru

Publisher: 'Springer Science and Business Media LLC'
Year: 2008
DOI identifier: 10.1186/1756-0500-1-2
OAI identifier: oai:researchonline.lshtm.ac.uk:7309
Provided by: LSHTM Research Online

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. Association and Royal Pharmaceutical Society of Great Britain. British National Formulary. London:
  2. Cardiovascular disease. In: Charlton J, Murphy MB (eds). The Health of Adult Britain,
  3. Changing the diagnostic criteria for myocardial infarction in patients with a suspected heart attack affects the measurement of 30 day mortality but not long term survival.
  4. (2007). Coronary Heart Disease Statistics. London: British Heart Foundation,
  5. (2010). date last accessed).
  6. (2008). Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database. Pharmacoepidemiol Drug Saf
  7. Differential effects of aspirin and non-aspirin nonsteroidal antiinflammatory drugs in the primary prevention of myocardial infarction in postmenopausal women.
  8. (1999). European Observatory on Health Care Systems. Health Care Systems in Transition. United Kingdom: European Observatory on Health Care Systems,
  9. Evans A et al. Pre-hospital coronary care and coronary fatality in the Belfast and Glasgow MONICA populations.
  10. (2004). Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care
  11. (1988). Health and Deprivation: Inequality and the North.
  12. (2000). Health. Coronary Heart Disease: National Service Framework for Coronary Heart Disease—Modern Standards and Service Models. London: Department of Health,
  13. (2009). Increased risk of myocardial infarction and stroke following exacerbation of chronic obstructive pulmonary disease. Chest
  14. (1999). Ma ¨ho ¨nen M et al. Contribution of trends in survival and coronary-events rates to changes in coronary heart disease mortality: 10 years results from 37 WHO MONICA Project populations. Lancet
  15. (2001). Multilevel Modelling of Health Statistics,1 s t edn.
  16. Nonsteroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population.
  17. (2006). Office for National Statistics. Population Estimates for UK, England and Wales. Scotland and
  18. (2006). Office for National Statistics. Regional Trends. In: Phillpotts G, Causer P (eds). London: Office for National Statistics,
  19. (2005). Office for National Statistics. T01. Mid-2004 Population Estimates: United Kingdom; Estimated Resident Population by Single Year of Age and Sex; revised due to Harrow Correction. Office for National Statistics,
  20. Office of Public Sector Information.
  21. (1998). Office of Public Sector Information. Government of Wales Act
  22. (2000). Office of Public Sector Information. The Northern Ireland Act
  23. (1994). on behalf of the United Kingdom Heart Attack Study Collaborative Group. Fatality outside hospital from acute coronary events in three British health districts,
  24. (2008). Regional and social differences in Coronary Heart Disease. London: British Heart Foundation,
  25. Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population.
  26. The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf
  27. The National Assembly for Wales. Tackling CHD in Wales: Implementing Through Evidence. Cardiff: National Assembly for Wales,
  28. (2005). The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf
  29. The risk of myocardial infarction associated with antihypertensive drug treatment in persons with uncomplicated essential hypertension.
  30. (2002). The Scottish Office. Coronary Heart Disease and Stroke: Strategy for Scotland. In: Office TS (eds). Edinburgh: The Scottish Office,
  31. (1997). The Stationary Office,
  32. Trends in casefatality in 117718 patients admitted with acute myocardial infarction in Scotland.
  33. (1978). Trends in rates of different forms of diagnosed coronary heart disease,
  34. Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death.
  35. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.
  36. (2006). Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf